Physicochemical Properties
| Molecular Formula | C21H21NO3S2 |
| Molecular Weight | 399.53 |
| Exact Mass | 399.096 |
| CAS # | 21306-65-0 |
| PubChem CID | 9583267 |
| Appearance | Typically exists as solid at room temperature |
| LogP | 6.484 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 27 |
| Complexity | 577 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | CC1=CC=C(C=C1)S(=O)(=O)N=S(C)C2=CC=C(C=C2)OCC3=CC=CC=C3 |
| InChi Key | IMUPOWQOXOCVBN-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C21H21NO3S2/c1-17-8-14-21(15-9-17)27(23,24)22-26(2)20-12-10-19(11-13-20)25-16-18-6-4-3-5-7-18/h3-15H,16H2,1-2H3 |
| Chemical Name | (NE)-4-methyl-N-[methyl-(4-phenylmethoxyphenyl)-λ4-sulfanylidene]benzenesulfonamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Nuclear factor I/CCAAT box transcription factor (NFI/CTF) is present in pirin, a nuclear protein. Pirin proteins are thought to be a member of the cupin superfamily because of their great degree of conservation among prokaryotes, plants, fungus, and mammals. The TPh A (20 μM; 5 hr) decreases the quantity of Bcl3 bound to pirin and hinders the interaction with glutathione S-transferase (GST) purLldown assay. HEK293T cells transfected with Myc and pirin-His6 vectors for 43 hours showed differences between pirin and Bcl3 [1]. While TPh A (0-100 μM; 48 hours) is active against MCF7, MDA-MB231, HeLa, DU145, HepG2, A549, HT1080, WM266-4, and SK, it lacks potent cytotoxic activity against many other human cancer cell lines. The IC50 values for MEL-28 cells are >50 μM, while those for PC3 HL60 and HT29 cells are 27 μM, 20 μM, and 26 μM, respectively [1]. WM266-4 and SK-MEL-28 cells' ability to migrate is inhibited by TPhA (0-50 μM; 48 hours) in a concentration-dependent manner [1]. |
| Cell Assay |
Cell Viability Assay[1] Cell Types: MCF7, MDA-MB231, HeLa, DU145, HepG2, A549, HT1080, WM266-4, and SK-MEL-28 cells Tested Tested Concentrations: 0-100 μM Incubation Duration: 48 hrs (hours) Experimental Results: Did not exert any potent cytotoxic activity against many human cancer cell lines. |
| References |
[1]. A Small-Molecule Inhibitor Shows That Pirin Regulates Migration of Melanoma Cells. Nat Chem Biol. 2010 Sep;6(9):667-73. |
Solubility Data
| Solubility (In Vitro) | DMSO: 250 mg/mL (625.74 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (5.21 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (5.21 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (5.21 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.5029 mL | 12.5147 mL | 25.0294 mL | |
| 5 mM | 0.5006 mL | 2.5029 mL | 5.0059 mL | |
| 10 mM | 0.2503 mL | 1.2515 mL | 2.5029 mL |